AGP Picks
View all

Sci-Tech North Carolina
Provided by AGP

Sci-Tech North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 12, 2026

Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 12, 2026

Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance
Aug. 12, 2026

Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance

Indeterminate GlobeNewswire
Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
Aug. 12, 2026

Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434

Indeterminate GlobeNewswire
Octave Announces Second Quarter 2026 Financial Results
Aug. 12, 2026

Octave Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis
Aug. 12, 2026

Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis

Indeterminate GlobeNewswire
TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 12, 2026

TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
Aug. 12, 2026

Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
Aug. 12, 2026

Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire
Kamada Announces Planned Transition of Chief Financial Officer
Aug. 12, 2026

Kamada Announces Planned Transition of Chief Financial Officer

Indeterminate GlobeNewswire
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
Aug. 12, 2026

Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
Aug. 12, 2026

LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer

Indeterminate GlobeNewswire
Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
Aug. 12, 2026

Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study

Indeterminate GlobeNewswire
Zapata Quantum Partners with QuEra to Advance the Commercial Viability of Quantum Applications
Aug. 12, 2026

Zapata Quantum Partners with QuEra to Advance the Commercial Viability of Quantum Applications

Indeterminate GlobeNewswire
Persephone Biosciences Publishes Largest U.S. Clinical Study of an Infant Synbiotic in Pediatric Research, Expanding Clinical Evidence for Its Infant Synbiotics
Aug. 12, 2026

Persephone Biosciences Publishes Largest U.S. Clinical Study of an Infant Synbiotic in Pediatric Research, Expanding Clinical Evidence for Its Infant Synbiotics

Indeterminate GlobeNewswire
Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates
Aug. 12, 2026

Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates

Indeterminate GlobeNewswire
Aurora Mobile's Modellix Adds PixVerse V6: Finished-Grade Video in One Request
Aug. 12, 2026

Aurora Mobile's Modellix Adds PixVerse V6: Finished-Grade Video in One Request

Indeterminate GlobeNewswire
RedCloud Signs India MOUs to Deploy Its RAID and CORE Engines Targeting 11 Apparel Brands, 25,000+ SKUs and 1,250+ Buyer Points
Aug. 12, 2026

RedCloud Signs India MOUs to Deploy Its RAID and CORE Engines Targeting 11 Apparel Brands, 25,000+ SKUs and 1,250+ Buyer Points

Indeterminate GlobeNewswire
Qintess Commits to a Minimum $6.5 Million Spend on Fusemachines Agentic AI Products and Services Over Three Years
Aug. 12, 2026

Qintess Commits to a Minimum $6.5 Million Spend on Fusemachines Agentic AI Products and Services Over Three Years

Indeterminate GlobeNewswire
Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug. 12, 2026

Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Einride and DAF Partner to Accelerate Scale-up of Autonomous Electric Freight
Aug. 12, 2026

Einride and DAF Partner to Accelerate Scale-up of Autonomous Electric Freight

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech North Carolina

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.